Trial Outcomes & Findings for Effectiveness of Transdiagnostic Cognitive Behavioral Therapy for Improving HIV Treatment Outcomes in South Africa (NCT NCT04242992)

NCT ID: NCT04242992

Last Updated: 2026-02-19

Results Overview

The proportion of participants who are virally suppressed (\<50 copies/mL) by 12 months post randomization

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

399 participants

Primary outcome timeframe

12 months post randomization

Results posted on

2026-02-19

Participant Flow

Note that partners are not enrolled in the study, they are only enrolled in CETA and as such are not study subjects.

Participant milestones

Participant milestones
Measure
CETA (Common Elements Treatment Approach)
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Active Control
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
3 Month Follow up Assesment
STARTED
202
197
3 Month Follow up Assesment
COMPLETED
156
147
3 Month Follow up Assesment
NOT COMPLETED
46
50
12 Month Follow up Assessment
STARTED
202
197
12 Month Follow up Assessment
COMPLETED
136
147
12 Month Follow up Assessment
NOT COMPLETED
66
50

Reasons for withdrawal

Reasons for withdrawal
Measure
CETA (Common Elements Treatment Approach)
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Active Control
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
3 Month Follow up Assesment
Did not complete 3 month assessment
46
50
12 Month Follow up Assessment
Did not complete 12 month assessment
66
50

Baseline Characteristics

Effectiveness of Transdiagnostic Cognitive Behavioral Therapy for Improving HIV Treatment Outcomes in South Africa

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CETA (Common Elements Treatment Approach)
n=202 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Active Control
n=197 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
Total
n=399 Participants
Total of all reporting groups
Age, Continuous
40.4 years
STANDARD_DEVIATION 8.3 • n=4 Participants
40.9 years
STANDARD_DEVIATION 9.3
40.6 years
STANDARD_DEVIATION 8.8 • n=4 Participants
Sex: Female, Male
Female
202 Participants
n=4 Participants
197 Participants
399 Participants
n=4 Participants
Sex: Female, Male
Male
0 Participants
n=4 Participants
0 Participants
0 Participants
n=4 Participants
Race/Ethnicity, Customized
Black African
196 Participants
n=4 Participants
192 Participants
388 Participants
n=4 Participants
Race/Ethnicity, Customized
Coloured
2 Participants
n=4 Participants
5 Participants
7 Participants
n=4 Participants
Race/Ethnicity, Customized
Missing
4 Participants
n=4 Participants
0 Participants
4 Participants
n=4 Participants
Region of Enrollment
South Africa
202 participants
n=4 Participants
197 participants
399 participants
n=4 Participants

PRIMARY outcome

Timeframe: 12 months post randomization

Population: Since this outcome was determined using medical records data, the available denominators for each arm are the original numbers randomized.

The proportion of participants who are virally suppressed (\<50 copies/mL) by 12 months post randomization

Outcome measures

Outcome measures
Measure
Active Control
n=197 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=202 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
12 Month Viral Suppression
86 Participants
86 Participants

SECONDARY outcome

Timeframe: 3 months post randomization

Population: 55 of the 202 CETA participants and 34 of the 197 Control participants had a viral load at 3 months for analysis

The proportion of participants who are virally suppressed (\<50 copies/mL) by 3 months post randomization of those with a viral load at 3 months of follow-up

Outcome measures

Outcome measures
Measure
Active Control
n=34 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=55 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
3 Month Viral Suppression
13 Participants
25 Participants

SECONDARY outcome

Timeframe: 12 months post randomization

Attrition rate (the opposite of retention) will be defined as the proportion of participants being more than 90 days late for a study visit 12 months post randomization.

Outcome measures

Outcome measures
Measure
Active Control
n=197 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=202 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
12 Month Attrition Rate
38 Participants
49 Participants

SECONDARY outcome

Timeframe: 3 months

Violence will be measured using the Severity of Violence Against Women Scale (SVAWS) physical/sexual violence subscale, a 27 item measure with a possible range of 27-108 and higher scores associated with greater severity of experienced violence.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=156 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Violence Against Women at 3 Months
37.0 score on a scale
Interval 35.6 to 38.4
37.0 score on a scale
Interval 35.3 to 38.9

SECONDARY outcome

Timeframe: 12 months

Violence will be measured using the Severity of Violence Against Women Scale (SVAWS) physical/sexual violence subscale, a 27 item measure with a possible range of 27-108 and higher scores associated with greater severity of experienced violence.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=136 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Violence Against Women at 12 Months
37.1 score on a scale
Interval 35.4 to 38.8
35.2 score on a scale
Interval 33.9 to 36.6

SECONDARY outcome

Timeframe: 3 months

Substance use will be measured with the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST), which includes 7 items on frequency of use, abuse, and dependence symptoms for the following substance types: tobacco, alcohol, inhalants, marijuana, cocaine, amphetamines, sedatives, hallucinogens, opioids , or other substance. Higher scores are associated with greater substance involvement. ASSIST is a binary outcome of yes/no to any past-three month substance use, it is not a continuous measure. Scores can range from 0 to 1.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=156 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Substance Use at 3 Months
0.1 score on a scale
Interval 0.1 to 0.2
0.1 score on a scale
Interval 0.08 to 0.2

SECONDARY outcome

Timeframe: 12 months

Substance use will be measured with the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST), which includes 7 items on frequency of use, abuse, and dependence symptoms for the following substance types: tobacco, alcohol, inhalants, marijuana, cocaine, amphetamines, sedatives, hallucinogens, opioids , or other substance. Higher scores are associated with greater substance involvement. ASSIST is a binary outcome of yes/no to any past-three month substance use, it is not a continuous measure. Scores can range from 0 to 1.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=136 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Substance Use at 12 Months
0.2 score on a scale
Interval 0.1 to 0.3
0.1 score on a scale
Interval 0.06 to 0.2

SECONDARY outcome

Timeframe: 3 months

PTSD symptoms will be assessed using 16 items scored on a four-point scale (1 = none, 2 = some of the time, 3 = a lot of the time, 4 = most of the time) from the Harvard Trauma Questionnaire (HTQ). HTQ scores can range from 1-4. Higher scores are associated with greater PTSD symptom severity.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=156 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Post-traumatic Stress Disorder (PTSD) Symptoms at 3 Months
1.8 score on a scale
Interval 1.7 to 1.9
1.6 score on a scale
Interval 1.5 to 1.7

SECONDARY outcome

Timeframe: 12 months

PTSD symptoms will be assessed using 16 items scored on a four-point scale (1 = none, 2 = some of the time, 3 = a lot of the time, 4 = most of the time) from the Harvard Trauma Questionnaire (HTQ). HTQ scores can range from 1-4. Higher scores are associated with greater PTSD symptom severity.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=136 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Post-traumatic Stress Disorder (PTSD) Symptoms at 12 Months
1.9 score on a scale
Interval 1.8 to 2.0
1.7 score on a scale
Interval 1.6 to 1.9

SECONDARY outcome

Timeframe: 3 months

CES-D is a 20-item scale of depression with a possible range of 0-60 (total scale score). Higher scores are associated with greater depression symptom severity.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=156 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Depression Based on the Epidemiological Studies-Depression Scale (CES-D) Scale Score at 3 Months
16.1 score on a scale
Interval 14.4 to 17.7
15.3 score on a scale
Interval 13.4 to 17.2

SECONDARY outcome

Timeframe: 12 months

CES-D is a 20-item scale of depression with a possible range of 0-60 (total scale score). Higher scores are associated with greater depression symptom severity.

Outcome measures

Outcome measures
Measure
Active Control
n=147 Participants
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
CETA (Common Elements Treatment Approach)
n=136 Participants
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Depression Based on the Epidemiological Studies-Depression Scale (CES-D) Scale Score at 12 Months
20.1 score on a scale
Interval 18.2 to 22.1
16.7 score on a scale
Interval 14.7 to 18.7

Adverse Events

CETA (Common Elements Treatment Approach)

Serious events: 12 serious events
Other events: 0 other events
Deaths: 1 deaths

Active Control

Serious events: 1 serious events
Other events: 0 other events
Deaths: 2 deaths

Serious adverse events

Serious adverse events
Measure
CETA (Common Elements Treatment Approach)
n=202 participants at risk
Participants randomized to CETA arm will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include Short Message Service (SMS) text reminders of their HIV care appointments, similar to the active control group. As of October 12, 2022 participants can elect to have CETA delivered by telephone.
Active Control
n=197 participants at risk
Participants randomized to the active control arm will receive usual care for intimate partner violence. Short Message Service (SMS) text messages will be sent monthly to our control group participants to remind them of HIV care appointments.
Respiratory, thoracic and mediastinal disorders
Hospitalized for difficulty breathing
0.00%
0/202 • 12 months
0.51%
1/197 • Number of events 1 • 12 months
Psychiatric disorders
Hospitalized for suicidal attempt
0.99%
2/202 • Number of events 2 • 12 months
0.00%
0/197 • 12 months
Social circumstances
Hospitalized because physically abused
0.99%
2/202 • Number of events 2 • 12 months
0.00%
0/197 • 12 months
Reproductive system and breast disorders
Hospitalized for fibroid surgery
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
Injury, poisoning and procedural complications
Hospitalized for food poisoning
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
Gastrointestinal disorders
Hospitalized for abdominal pain
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
Gastrointestinal disorders
Hospitalized for severe diarrhea
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
General disorders
Hospitalized for syncope
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
Social circumstances
Hospitalized for substance induced psychosis
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
Psychiatric disorders
Hospitalized for psychotic relapse
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months
General disorders
Hospitalized for car crash
0.50%
1/202 • Number of events 1 • 12 months
0.00%
0/197 • 12 months

Other adverse events

Adverse event data not reported

Additional Information

Matthew Fox, DSc, MPH

Boston University School of Public Health, Epidemiology and Global Health

Phone: 617-358-2062

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place